Summary
CEO Kim Min-soo and MC Park Hyun-sang analyze KOSDAQ's sharp bounce to 850, note resistance and lack of volume or leading stocks, and discuss sector strategy. Kim favors semiconductor materials/equipment (소부장) due to capex tailwinds and policy shifts, while urging traders to stay nimble, cut losses, and avoid getting stuck in a choppy, leaderless market.
- KOSDAQ rallied 35% from 600 to 850, but most participants only reduced losses rather than building new positions.
- Key resistance lies at 850, with next resistance at 930–950; volume and a clear leadership sector are missing.
- Semiconductor capex (Samsung's Yongin, Cheongju, Gwangju) and potential Q‑driven utilization gains support a medium‑term thesis for materials/parts/equipment (소부장).
- Government plans to delist marginal companies may favor profitable 소부장 names at the expense of unprofitable biotech.
- Biotech faces headwinds from elevated US rates (4.7%) and Alteogen’s technical resistance after a 60% bounce.
- Trading conditions remain difficult; Kim recommends short‑term rotations between biotech and 소부장, strict loss‑cutting, and keeping cash on hand.